11th European AIDS Conference (EACS)

HIV and Hepatitis.com Coverage of the
11th European AIDS Conference (EACS)
Madrid, Spain. October 24-27, 2007

	Library of Slides and Posters
	Guidelines
	HIV and AIDS Articles
	HIV-HCV Coinfection Articles

	HIV and AIDS Articles Top
No Excess Liver Toxicity Seen in Clinical Trials of Maraviroc (Selzentry)
Tipranavir (Aptivus) Has Similar In Vitro Antiviral Activity against Subtype B and Non-B Clinical Isolates of HIV-1
Combination of Tenofovir (Viread), Emtricitabine (Emtriva), and Nevirapine (Viramune) Demonstrates Potent Anti-HIV Activity
Growth Hormone-releasing Factor Tesamorelin (TH9507) Improves Abdominal Fat Accumulation, but Fat Returns after Drug is Stopped
48-Week Data Support a Switch from Combivir to Truvada in Virologically-suppressed HIV Patients: The SWEET Study
Lopinavir/ritonavir (Kaletra) Monotherapy Is Effective for Some Patients, but Once-daily Dosing Can be Risky without Optimal Adherence
HIV Patients with Advanced Disease Can Achieve Good Long-term Outcomes on HAART, but CD4 Cell Gains May Be Limited
Virological Suppression Is Maintained after Switch to Efavirenz/Emtricitabine/Tenofovir (Atripla) vs Continuation of Current Antiretroviral Therapy: 24-week Interim Efficacy Analyses
Once Daily Fosamprenavir (Lexiva) Boosted with Either 100 mg or 200 mg Ritonavir (Norvir): Efficacy Results from COL100758
Boosted Tipranavir (Aptivus) in Treatment-experienced HIV Patients: 3-year Data from RESIST-1 and RESIST-2
Efficacy and Safety of Ritonavir-boosted Saquinavir (Invirase) Versus Lopinavir/ritonavir (Kaletra): Final 48-week Results of the Gemini Study
Liver Profile of Tipranavir (Aptivus) in Treatment-experienced HIV Patients
European AIDS Clinical Society Issues New Guidelines for Treatment of HIV, HIV and Hepatitis Coinfection, and Management of Metabolic Complications
The Role of Adherence in Achieving and Maintaining Undetectable HIV RNA
The Role of Adherence in Immunological Response to Lopinavir/ritonavir (Kaletra) Regimens in Treatment-naive HIV Patients
.
	Guidelines Top
Guidelines for the Clinical Management and Treatment of HIV-infected Adults in Europe
Guidelines on the Prevention and Management of Metabolic Diseases in HIV
Guidelines for the Clinical Management and Treatment of Chronic Hepatitis B and C co-infection in HIV-infected Adults
.
	HIV-HCV Coinfection Articles Top
High Rate of Illness and Death in HIV-HCV Coinfected Patients with Advanced Liver Disease, but Hepatitis C Treatment Lowers the Risk

Madrid, Spain